The Effect of Erythrocyte Blood Transfusions on Survival After Surgery for Hip Fracture

被引:91
作者
Engoren, Milo [1 ]
Mitchell, Eric
Perring, Paul
Sferra, Joseph [2 ]
机构
[1] Univ Toledo, Dept Anesthesiol, Coll Med, St Vincent Mercy Med Ctr, Toledo, OH 43608 USA
[2] Univ Toledo, Coll Med, St Vincent Mercy Med Ctr, Dept Surg, Toledo, OH 43608 USA
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2008年 / 65卷 / 06期
关键词
Blood transfusion; Hip fracture; Survival; Mortality;
D O I
10.1097/TA.0b013e318157d9f9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background. studies in cardiac surgery patients have suggested that allogeneic erythrocyte blood transfusions are associated with an increased long-term mortality. However, studies in patients undergoing Surgery for hip fractures have found no effect of transfusion on short-term mortality, but did not evaluate the effects on long-term mortality. The purpose of this study is to analyze the effect of allogeneic erythrocyte blood transfusions on long-term mortality. Methods: Charts of all patients undergoing surgery for hip fracture (International Classification of Disease 820.0-820.9) between January 1, 2003 and December 31, 2005 were reviewed for demographic, comorbidities , laboratory values, use or and age of transfused blood products. Death was determined from the Social Security Death Index. Survival was analyzed with Cox models and Kaplan-Meier statistics. To control for biases in this retrospective study, a subpopulation was analyzed after propensity matching using Cox modeling. Results: Thirty-one of the 59 patients (53%) dead at follow-up had received allogeneic erythrocyte transfusions, compared with 59 of 170 survivors (35%) (p = 0.02). However, the increased risk of death was time dependent. Transfusion became a risk factor for death only after at least 90 days after surgery. By Cox modeling, transfusion was associated with an increased risk of death (relative risk = 3.386, 95% CI = 1.255-4.534,p = 0.01; c-statistic = 0.612 +/- 0.055, p = 0.03). Seventy-four (32%) of patients were matched using propensity analysis. Similar to the total population, the increased mortality associated with transfusion did not occur for at least 90 days. Using Cox proportional hazard modeling in propensity-matched patients who survived at least 90 days after surgery, transfusion remained a predictor of death (relative risk = 3.760, 95% CI = 1.216-11.626,p = 0.02). Conclusion: We found that use of allogeneic erythrocyte transfusions to patients undergoing surgical repair of hip fractures was associated with an increased risk of death. This risk started after 90 days from surgery and persisted the length of follow-up.
引用
收藏
页码:1411 / 1415
页数:5
相关论文
共 28 条
  • [1] Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma
    Asahara, T
    Katayama, K
    Itamoto, T
    Yano, M
    Hino, H
    Okamoto, Y
    Nakahara, H
    Dohi, K
    Moriwaki, K
    Yuge, O
    [J]. WORLD JOURNAL OF SURGERY, 1999, 23 (07) : 676 - 680
  • [2] RETRACTED: The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery (Retracted Article)
    Basran, Sukhjeewan
    Frumento, Robert J.
    Cohen, Allison
    Lee, Samuel
    Du, Yuling
    Nishanian, Ervant
    Kaplan, Harold S.
    Stafford-Smith, Mark
    Bennett-Guerrero, Elliott
    [J]. ANESTHESIA AND ANALGESIA, 2006, 103 (01) : 15 - 20
  • [3] Influence of storage on red blood cell rheological properties
    Berezina, TL
    Zaets, SB
    Morgan, C
    Spillert, CR
    Kamiyama, M
    Spolarics, Z
    Deitch, EA
    Machiedo, GW
    [J]. JOURNAL OF SURGICAL RESEARCH, 2002, 102 (01) : 6 - 12
  • [4] Transfusion immunomodulation or TRIM: What does it mean clinically?
    Blajchman, MA
    [J]. HEMATOLOGY, 2005, 10 : 208 - 214
  • [5] Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people
    Bruunsgaard, H
    Ladelund, S
    Pedersen, AN
    Schroll, M
    Jorgensen, T
    Pedersen, BK
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (01) : 24 - 31
  • [6] Bruunsgaard H, 2006, DAN MED BULL, V53, P285
  • [7] BURROWS L, 1982, LANCET, V2, P662
  • [8] Card R T, 1988, Transfus Med Rev, V2, P40, DOI 10.1016/S0887-7963(88)70030-9
  • [9] Perioperative blood transfusion and postoperative mortality
    Carson, JL
    Duff, A
    Berlin, JA
    Lawrence, VA
    Poses, RM
    Huber, EC
    O'Hara, DA
    Noveck, H
    Strom, BL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (03): : 199 - 205
  • [10] EFFECT OF TIMING OF ADMINISTRATION AND QUANTITY OF BLOOD-TRANSFUSION ON CADAVER RENAL-TRANSPLANT SURVIVAL
    CORRY, RJ
    WEST, JC
    HUNSICKER, LG
    SCHANBACHER, BA
    LACHENBRUCH, PA
    [J]. TRANSPLANTATION, 1980, 30 (06) : 425 - 428